B.C. is opening up access to a cutting edge blood cancer treatment, after years of it only being available through clinical trials or by travelling out of province.
Beginning this month, British Columbians battling some advanced types of leukemia and lymphomas will have the option of undergoing Chimeric Antigen Receptor T-Cell (CAR-T) therapy. The treatment works by extracting a patient’s white blood cells, genetically engineering them to recognize and fight cancer and then infusing them back into the patient’s bloodstream.